SPINK1 is a Potential Diagnostic and Prognostic Biomarker for Sepsis

References

• Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–1247. doi:10.1007/s00134-021-06506-y
   PubMed Web of Science ®Google Scholar
• Schorr C, Odden A, Evans L, et al. Implementation of a multicenter performance improvement program for early detection and treatment of severe sepsis in general medical-surgical wards. J Hosp Med. 2016;11 Suppl 1:S32–S39. doi:10.1002/jhm.2656
   PubMed Web of Science ®Google Scholar
• Alberto L, Marshall AP, Walker R, Aitken LM. Screening for sepsis in general hospitalized patients: a systematic review. J Hosp Infect. 2017;96(4):305–315. doi:10.1016/j.jhin.2017.05.005
   PubMed Web of Science ®Google Scholar
• Bhattacharjee P, Edelson DP, Churpek MM. Identifying patients with sepsis on the hospital wards. Chest. 2017;151(4):898–907. doi:10.1016/j.chest.2016.06.020
   PubMed Web of Science ®Google Scholar
• Nishibori M, Wake H, Morimatsu H. Histidine-rich glycoprotein as an excellent biomarker for sepsis and beyond. Crit Care. 2018;22(1):209. doi:10.1186/s13054-018-2127-5
   PubMedGoogle Scholar
• Barichello T, Generoso JS, Singer M, Dal-Pizzol F. Biomarkers for sepsis: more than just fever and leukocytosis-A narrative review. Crit Care. 2022;26(1):14. doi:10.1186/s13054-021-03862-5
   PubMed Web of Science ®Google Scholar
• El-Khazragy N, Mohamed NM, Mostafa MF, et al. miRNAs: novel noninvasive biomarkers as diagnostic and prognostic tools in neonatal sepsis. Diagn Microbiol Infect Dis. 2023;107(3):116053. doi:10.1016/j.diagmicrobio.2023.116053
   PubMed Web of Science ®Google Scholar
• Povoa P, Coelho L, Dal-Pizzol F, et al. How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive Care Med. 2023;49(2):142–153. doi:10.1007/s00134-022-06956-y
   PubMed Web of Science ®Google Scholar
• Kennis B, Ali A, Lasoff D, Sweeney DA, Wardi G. The diagnostic utility of procalcitonin is limited in the setting of methamphetamine toxicity. Am J Emerg Med. 2022;54:36–40. doi:10.1016/j.ajem.2022.01.049
   PubMed Web of Science ®Google Scholar
• Essmann L, Wirz Y, Gregoriano C, Schuetz P. One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitonin and other specific biomarkers. Expert Rev Mol Diagn. 2023;2023:1–14.
   Google Scholar
• Mun DG, Renuse S, Saraswat M, et al. PASS-DIA: a data-independent acquisition approach for discovery studies. Anal Chem. 2020;92(21):14466–14475. doi:10.1021/acs.analchem.0c02513
   PubMed Web of Science ®Google Scholar
• Luo M, Zhang Q, Hu Y, Sun C, Sheng Y, Deng C. LGALS3BP: a potential plasma biomarker associated with diagnosis and prognosis in patients with sepsis. Infect Drug Resist. 2021;14:2863–2871. doi:10.2147/IDR.S316402
   PubMed Web of Science ®Google Scholar
• Wang C, Li Y, Li S, Chen M, Hu Y. Proteomics combined with RNA sequencing to screen biomarkers of sepsis. Infect Drug Resist. 2022;15:5575–5587. doi:10.2147/IDR.S380137
   PubMed Web of Science ®Google Scholar
• Kazal LA, Spicer DS, Brahinsky RA. Isolation of a crystalline trypsin inhibitor-anticoagulant protein from pancreas. J Am Chem Soc. 1948;70(9):3034–3040. doi:10.1021/ja01189a060
   PubMed Web of Science ®Google Scholar
• Lin TC. Functional roles of SPINK1 in cancers. Int J Mol Sci. 2021;22(8):1.
   Web of Science ®Google Scholar
• Ruopp MD, Perkins NJ, Whitcomb BW, Schisterman EF. Youden index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J. 2008;50(3):419–430. doi:10.1002/bimj.200710415
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Sahin-Toth M. Human mesotrypsin defies natural trypsin inhibitors: from passive resistance to active destruction. Protein Pept Lett. 2005;12(5):457–464. doi:10.2174/0929866054395356
   PubMed Web of Science ®Google Scholar
• Itkonen O, Stenman UH. TATI as a biomarker. Clin Chim Acta. 2014;431:260–269. doi:10.1016/j.cca.2014.02.014
   PubMed Web of Science ®Google Scholar
• Liao C, Wang Q, An J, et al. SPINKs in tumors: potential therapeutic targets. Front Oncol. 2022;12:833741. doi:10.3389/fonc.2022.833741
   PubMedGoogle Scholar
• Jia J, Ga L, Liu Y, et al. Serine protease inhibitor kazal type 1, a potential biomarker for the early detection, targeting, and prediction of response to immune checkpoint blockade therapies in hepatocellular carcinoma. Front Immunol. 2022;13:923031. doi:10.3389/fimmu.2022.923031
   PubMedGoogle Scholar
• Stevens C, Hightower A, Buxbaum SG, Falzarano SM, Rhie SK. Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients. Front Oncol. 2023;13:1079037. doi:10.3389/fonc.2023.1079037
   PubMed Web of Science ®Google Scholar
• Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–710. doi:10.1007/BF01709751
   PubMed Web of Science ®Google Scholar
• Wang X, Guo Z, Chai Y, et al. Application prospect of the SOFA score and related modification research progress in sepsis. J Clin Med. 2023;12(10):1.
   Web of Science ®Google Scholar
• Qiu X, Lei YP, Zhou RX. SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2023;21(8):891–900. doi:10.1080/14787210.2023.2237192
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–829. doi:10.1097/00003246-198510000-00009
   PubMed Web of Science ®Google Scholar
• Baldira J, Ruiz-Rodriguez JC, Ruiz-Sanmartin A, et al. Use of Biomarkers to improve 28-day mortality stratification in patients with sepsis and SOFA </= 6. Biomedicines. 2023;11(8). doi:10.3390/biomedicines11082149
   PubMed Web of Science ®Google Scholar